Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
Consumer (CDRH/FDA) (Consumer Photo Montage)
Skip Consumer NavigationConsumer Home Product Information Choosing a Medical Device How We Can Help Resources Problems with Medical Devices

(See Related Information) New Device Approval

(photograph of product)INFUSE® Bone Graft - P050053

This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval.

Product Name: INFUSE® Bone Graft
PMA Applicant: Medtronic Sofamor Danek
Address: 1800 Pyramid Place, Memphis, Tennessee 38132
Approval Date: March 9, 2007
Approval Letter: http://www.fda.gov/cdrh/pdf5/p050053a.pdf

What is it? INFUSE® Bone Graft is a bone filling material for dental use, and contains a bone protein. It is an alternative to grafting a patient’s own bone.

How does it work? INFUSE® Bone Graft is used to fill space where bone is needed in order to place endosseous dental implants. Endosseous dental implants are inserted in the jaw and have an exposed head that can be used to secure dental devices like a crown, fixed bridge, or dentures.

When is it used? INFUSE® Bone Graft is used in making enough bone in the sinus area to place endosseous dental implants in the upper jaw. It is also used to increase bone in extraction sites prior to implant placement.

What will it accomplish? INFUSE® Bone Graft accomplishes almost the same clinical outcome as grafting a patient’s own bone into these locations but without the difficulties of grafting bone from the hip and other sites. Grafting sites usually have many side effects including pain and long recovery times.

When should it not be used? INFUSE® Bone Graft should not be used:

Additional information: The Summary of Safety and Effectiveness and labeling are available at: http://www.fda.gov/cdrh/pdf5/p050053.html

Other:

Updated March 13, 2007

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH